The Scientist

» drug safety

Most Recent

image: Chronic Weed Use Shrinks Brain Region

Chronic Weed Use Shrinks Brain Region

By | November 12, 2014

Long-term marijuana smokers have less gray matter in their orbitofrontal cortex than nonsmokers, but other brain circuits may compensate by increasing connectivity.

2 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: Opinion: Regenerating Safely

Opinion: Regenerating Safely

By | January 21, 2013

Patient safety is paramount in regulating new stem cell treatments.

1 Comment

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Call for Diabetes Drug Ban

Call for Diabetes Drug Ban

By | April 30, 2012

A consumer advocacy group calls for a ban of a diabetes drug after evidence surfaces that it may increase the risk of cancer.

0 Comments

image: FDA Ups Recent Recalls

FDA Ups Recent Recalls

By | November 9, 2011

The US regulatory agency recalled 54 percent more drugs from the second to third quarters of 2011.

3 Comments

image: Opinion: Sustainable Drug Monitoring

Opinion: Sustainable Drug Monitoring

By | August 31, 2011

Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.

3 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
The Scientist